Organisation paid for research Program year 2024 Source: CMS Open Payments

Beals Institute PC

Neither a doctor nor a teaching hospital

Research payments

$14,991

10 payments

Through program year 2024, Beals Institute PC is reported as receiving $14,991 in research payments, across 10 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$1,275	2
2020	Research	$90	1
2019	Research	$13,626	7

Breakdown

Who paid Research payments · program years 2019–2024

AbbVie, Inc. $7,477 4 payments
Pfizer Inc. $3,870 2 payments
Amgen Inc. $1,425 2 payments
Gilead Sciences, Inc. $1,200 1 payment
Eli Lilly and Company $1,019 1 payment

Studies the money was for Research payments · program years 2019–2024

M16-063 $6,082 1 payment
Phase III Pivotal Study 1 of Tofacitinib Cp690550 in Ankylosing Spondylitis $3,870 2 payments
Enbrel RA Remission Study $1,425 2 payments
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) $1,275 2 payments
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib and GS-9876 in Female Subjects with Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) $1,200 1 payment
A Randomized, Active-Controlled, Parallel-Group, Phase 3B/4 Study of Baricitinib in Patients With Rheumatoid Arthritis $1,019 1 payment
M15-572 $120 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.